MedPath
HSA Approval

YSP ALLOPURINOL TABLET 300MG

SIN17004P

YSP ALLOPURINOL TABLET 300MG

YSP ALLOPURINOL TABLET 300MG

May 8, 2024

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

M04AA01

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y.S.P. Industries (M) Sdn. Bhd.

Active Ingredients

ALLOPURINOL

300 mg

Allopurinol

Documents

Package Inserts

YSP Allopurinol Tablet PI.pdf

Approved: May 8, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.